A randomized double-blind phase III study of niraparib versus placebo as maintenance therapy in extensive-stage small cell lung cancer

被引：0
|
作者：
Ai, X. [1 ]
Pan, Y. [2 ]
Shi, J. [3 ]
Yang, N. [4 ]
Liu, C. [5 ]
Zhou, J. [6 ]
Zhang, X. [7 ]
Dong, X. [8 ]
He, J. [9 ]
Li, X. [10 ,12 ]
Chen, G. [11 ]
Li, X. [10 ,12 ]
Zhang, H. [13 ]
Liao, W. [14 ]
Zhang, Y. [15 ]
Ma, Z. [16 ]
Zhang, B. [17 ]
Zhang, D. [17 ]
Lu, S. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China
[2] Anhui Prov Hosp, Dept Chemotherapy, Hefei, Anhui, Peoples R China
[3] Linyi Canc Hosp, Dept Med Oncol, Linyi, Shandong, Peoples R China
[4] Hunan Canc Hosp, Lung & Gastrointestinal Oncol Dept, Changsha, Hunan, Peoples R China
[5] Xinjiang Med Univ, Canc Hosp, Dept Pulm Med, Urumqi, Peoples R China
[6] Zhejiang Univ, Affiliated Hosp 1, Dept Resp Med, Hangzhou, Zhejiang, Peoples R China
[7] Nantong Tumor Hosp, Dept Med Oncol, Nantong, Peoples R China
[8] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan, Hubei, Peoples R China
[9] Guangzhou Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Guangzhou, Guangdong, Peoples R China
[10] Liaoning Canc Hosp & Inst, Dept Thorac Med, Shenyang, Peoples R China
[11] Harbin Med Univ Canc Hosp, Dept Resp Med, Harbin, Heilongjiang, Peoples R China
[12] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Henan, Peoples R China
[13] Tangdu Hosp, Dept Oncol, Xian, Shaanxi, Peoples R China
[14] Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China
[15] Zhejiang Canc Hosp, Dept Thorac Medial Oncol, Hangzhou, Zhejiang, Peoples R China
[16] Zhengzhou Univ, Dept Med Oncol, Affiliated Canc Hosp, Henan Canc Hosp, Zhengzhou, Henan, Peoples R China
[17] Zai Lab Shanghai Co Ltd, R&D Dept, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.10.371
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
377O
引用
收藏
页码：S1387 / S1387
页数：1
相关论文
共 50 条
  • [1] Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study
    Rudin, Charles M.
    Awad, Mark M.
    Navarro, Alejandro
    Gottfried, Maya
    Peters, Solange
    Csoszi, Tibor
    Cheema, Parneet K.
    Rodriguez-Abreu, Delvys
    Wollner, Mirjana
    Yang, James Chih-Hsin
    Mazieres, Julien
    Orlandi, Francisco J.
    Luft, Alexander
    Gumus, Mahmut
    Kato, Terufumi
    Kalemkerian, Gregory P.
    Luo, Yiwen
    Ebiana, Victoria
    Pietanza, M. Catherine
    Kim, Hye Ryun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (21) : 2369 - +
  • [2] SALUTE: a placebo-controlled, double-blind, multicenter, randomized, phase II study of bevacizumab in previously untreated extensive-stage small cell lung cancer (SCLC)
    Spigel, David R.
    Townley, Peter M.
    Waterhouse, David M.
    Fang Liang
    Adiguzel, Ibrahim
    Huang, Jane E.
    Scappaticci, Frank A.
    Socinski, Mark A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S398 - S398
  • [3] Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer receiving chemotherapy: Results from a randomized, double-blind, placebo-controlled phase III study (TRACES)
    Cheng, Ying
    Wu, Lin
    Huang, Dingzhi
    Wang, QiMing
    Fan, Yun
    Zhang, XiQin
    Fan, HuiJie
    Yao, WenXiu
    Liu, BaoGang
    Yu, GuoHua
    Pan, YueYin
    Xu, Fei
    He, ZhiYong
    Dong, XiaoRong
    Ma, Rui
    Min, XuHong
    Ge, XiaoSong
    Chen, Hualin
    Liu, Qun
    Hu, YanPing
    Liu, Ying
    Yang, Chen
    Yang, Yang
    Li, Xiucui
    Zhou, Li
    LUNG CANCER, 2024, 188
  • [4] Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance)
    Ready, Neal E.
    Pang, Herbert H.
    Gu, Lin
    Otterson, Gregory A.
    Thomas, Sachdev P.
    Miller, Antonius A.
    Baggstrom, Maria
    Masters, Gregory A.
    Graziano, Stephen L.
    Crawford, Jeffrey
    Bogart, Jeffrey
    Vokes, Everett E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15) : 1660 - +
  • [5] A Phase 1b/2 Study of Niraparib Plus Temozolomide Versus Standard Care as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer Patients
    Cummings, A.
    Garon, E.
    Wainberg, Z.
    Goldman, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S543 - S543
  • [6] A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancer
    Chen, Zhiwei
    Chen, Jianhua
    Huang, Dingzhi
    Zhang, Wei
    Wu, Lin
    Yi, Tienan
    Wang, Qiming
    Han, Liang
    Tan, Liping
    Li, Yinyin
    Zhang, Zhihong
    Li, Na
    Li, Jie
    Zhang, Tongmei
    Hu, Ying
    Sun, Hongmei
    Wu, Youhua
    He, Zhiyong
    Yang, Runxiang
    Cheng, Peng
    Li, Xingya
    Shi, Jianhua
    Yu, Guohua
    Ma, Daiyuan
    Li, Benjamin Xiaoyi
    Dai, Xiangrong
    Wong, Michael
    Li, Yujie
    Yu, Xiaohui
    Lu, Shun
    Socazolimab Study Grp, Benjamin Xiaoyi
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
  • [7] A PHASE 2 STUDY OF TORIPALIMAB PLUS ANLOTINIB AS MAINTENANCE THERAPY IN EXTENSIVE-STAGE SMALL CELL LUNG CANCER
    Lv, Dongqing
    Wu, Guixian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A497 - A497
  • [8] Efficacy and Safety of Niraparib as Maintenance Treatment in Patients With Extensive-Stage SCLC After First-Line Chemotherapy: A Randomized, Double-Blind, Phase 3 Study
    Ai, Xinghao
    Pan, Yueyin
    Shi, Jianhua
    Yang, Nong
    Liu, Chunling
    Zhou, Jianying
    Zhang, Xiaodong
    Dong, Xiaorong
    He, Jianxing
    Li, Xiaoling
    Chen, Gongyan
    Li, Xingya
    Zhang, Helong
    Liao, Wangjun
    Zhang, Yiping
    Ma, Zhiyong
    Jiang, Liyan
    Cui, Jiuwei
    Hu, Chunhong
    Wang, Wei
    Huang, Cheng
    Zhao, Jun
    Ding, Cuimin
    Hu, Xiaohua
    Wang, Kai
    Gao, Beili
    Song, Yong
    Liu, Xiaoqing
    Xiong, Jianping
    Liu, Anwen
    Li, Junling
    Liu, Zhe
    Li, Yinyin
    Wang, Mengzhao
    Zhang, Biao
    Zhang, Dan
    Lu, Shun
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (08) : 1403 - 1414
  • [9] A phase II study of toripalimab plus anlotinib as maintenance therapy in extensive-stage small cell lung cancer.
    Lv, Dongqing
    Wu, Guixian
    Lin, Xiaomai
    Lin, Ling
    Pan, Weijia
    CANCER RESEARCH, 2021, 81 (13)
  • [10] The Retrospective Analysis of Apatinib as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer
    Yan, X.
    Ma, Z.
    Wang, H.
    Li, P.
    Zheng, X.
    Zhang, G.
    Zhang, M.
    Yang, J.
    Zhang, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) : S174 - S174
12345